AIMS: To report pain and functional interference responses in patients radiated for painful spinal metastases, and to determine if location within the vertebral column or dose fractionation are associated with response. MATERIALS AND METHODS: Patients treated with palliative radiotherapy for symptomatic spinal metastases from May 2003 to June 2005 were analysed. All patients completed the Brief Pain Inventory (BPI) assessment tool at 1, 2 and 3 months after radiotherapy. The pain response was determined using the International Bone Metastases Consensus response definitions. Given seven BPI functional interference items, a Bonferroni adjusted P value of less than 0.007 was considered significant. RESULTS: One hundred and nine treated patients were assessed. About 50% of patients were treated with a single fraction of 8Gy. All pain scores and functional interference scores significantly decreased over time after radiotherapy. At 3 months, 64% of patients achieved a response. Mood was significantly improved for responders (P=0.003) and a trend in improvement was observed for general activity (P=0.01) and normal work (P=0.04). Breast and prostate primaries were more likely to achieve an early response as compared with a lung primary. Neither location within the vertebral column or radiotherapy dose fractionation independently predicted for pain or functional interference responses. CONCLUSION: Conventional radiotherapy with 8Gy in a single fraction for spine metastases resulted in effective palliation of pain at 3 months and had a positive effect on a patient's mood. Location within the spine was not a predictive factor.
AIMS: To report pain and functional interference responses in patients radiated for painful spinal metastases, and to determine if location within the vertebral column or dose fractionation are associated with response. MATERIALS AND METHODS:Patients treated with palliative radiotherapy for symptomatic spinal metastases from May 2003 to June 2005 were analysed. All patients completed the Brief Pain Inventory (BPI) assessment tool at 1, 2 and 3 months after radiotherapy. The pain response was determined using the International Bone Metastases Consensus response definitions. Given seven BPI functional interference items, a Bonferroni adjusted P value of less than 0.007 was considered significant. RESULTS: One hundred and nine treated patients were assessed. About 50% of patients were treated with a single fraction of 8Gy. All pain scores and functional interference scores significantly decreased over time after radiotherapy. At 3 months, 64% of patients achieved a response. Mood was significantly improved for responders (P=0.003) and a trend in improvement was observed for general activity (P=0.01) and normal work (P=0.04). Breast and prostate primaries were more likely to achieve an early response as compared with a lung primary. Neither location within the vertebral column or radiotherapy dose fractionation independently predicted for pain or functional interference responses. CONCLUSION: Conventional radiotherapy with 8Gy in a single fraction for spine metastases resulted in effective palliation of pain at 3 months and had a positive effect on a patient's mood. Location within the spine was not a predictive factor.
Authors: Edward Chow; Ralph M Meyer; Bingshu E Chen; Yvette M van der Linden; Daniel Roos; William F Hartsell; Peter Hoskin; Jackson S Y Wu; Abdenour Nabid; Caroline J A Tissing-Tan; Bing Oei; Scott Babington; William F Demas; Carolyn F Wilson; Rebecca K S Wong; Michael Brundage Journal: J Clin Oncol Date: 2014-10-27 Impact factor: 44.544
Authors: Rachit Kumar; Anick Nater; Ahmed Hashmi; Sten Myrehaug; Young Lee; Lijun Ma; Kristin Redmond; Simon S Lo; Eric L Chang; Albert Yee; Charles G Fisher; Michael G Fehlings; Arjun Sahgal Journal: Neurooncol Pract Date: 2015-07-27
Authors: David D Howell; Jennifer L James; William F Hartsell; Mohan Suntharalingam; Mitchell Machtay; John H Suh; William F Demas; Howard M Sandler; Lisa A Kachnic; Lawrence B Berk Journal: Cancer Date: 2012-11-16 Impact factor: 6.860
Authors: Joanne M van der Velden; Anne L Versteeg; Helena M Verkooijen; Charles G Fisher; Edward Chow; F Cumhur Oner; Marco van Vulpen; Lorna Weir; Jorrit-Jan Verlaan Journal: Oncologist Date: 2017-05-03
Authors: Zain A Husain; Isabelle Thibault; Daniel Letourneau; Lijun Ma; Harald Keller; John Suh; Veronica Chiang; Eric L Chang; Raja K Rampersaud; James Perry; David A Larson; Arjun Sahgal Journal: CNS Oncol Date: 2013-05
Authors: Isabelle Thibault; Eshetu G Atenafu; Eric Chang; Sam Chao; Al-Omair Ameen; Stephanie Zhou; Nicholas Boehling; Ehsan H Balagamwala; Marcelo Cunha; John Cho; Lilyana Angelov; Paul D Brown; John Suh; Laurence D Rhines; Michael G Fehlings; Arjun Sahgal Journal: J Radiosurg SBRT Date: 2015
Authors: Alfonso Gomez-Iturriaga; Jon Cacicedo; Arturo Navarro; Virginia Morillo; Patricia Willisch; Claudia Carvajal; Eduardo Hortelano; Jose Luis Lopez-Guerra; Ana Illescas; Francisco Casquero; Olga Del Hoyo; Raquel Ciervide; Ana Irasarri; Jose Ignacio Pijoan; Pedro Bilbao Journal: BMC Palliat Care Date: 2015-10-01 Impact factor: 3.234